OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
30
Results
Show all
Save search
Copy query
Show results for
Unknown
(30)
Publication Date
Release Date
2021
(8)
2025
(5)
2024
(4)
2023
(3)
2017
(3)
2020
(2)
2019
(2)
2022
(1)
2016
(1)
2015
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Distinct immune responses to proton and photon radiotherapy: implications for anti-PD-L1 combination therapy in colorectal cancer.
Not available
S-EPMC11931879
|
biostudies-literature
Cite
Impact of proton therapy on antitumor immune response.
Not available
S-EPMC8241828
|
biostudies-literature
Cite
Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer.
Not available
S-EPMC8345055
|
biostudies-literature
Cite
RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.
Not available
S-EPMC6442988
|
biostudies-literature
Cite
A Modular Supramolecular Peptide Platform Reveals Atomic-Number-Dependent Mechanisms Driving Radioenhancement.
Not available
S-EPMC12676735
|
biostudies-literature
Cite
Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment.
Not available
S-EPMC10253893
|
biostudies-literature
Cite
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.
Not available
S-EPMC7404899
|
biostudies-literature
Cite
Newly diagnosed rheumatic heart disease among indigenous populations in the Pacific.
Not available
S-EPMC4680122
|
biostudies-literature
Cite
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study.
Not available
S-EPMC8787862
|
biostudies-literature
Cite
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Not available
S-EPMC10726239
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets